Quantifying exploratory low dose compounds in humans with AMS
- 31 October 2010
- journal article
- review article
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 63 (7), 518-531
- https://doi.org/10.1016/j.addr.2010.10.009
Abstract
Accelerator Mass Spectrometry is an established technology whose essentiality extends beyond simply a better detector for radiolabeled molecules. Attomole sensitivity reduces radioisotope exposures in clinical subjects to the point that no population need be excluded from clinical study. Insights in human physiochemistry are enabled by the quantitative recovery of simplified AMS processes that provide biological concentrations of all labeled metabolites and total compound related material at non-saturating levels. In this paper, we review some of the exploratory applications of AMS 14C in toxicological, nutritional, and pharmacological research. This body of research addresses the human physiochemistry of important compounds in their own right, but also serves as examples of the analytical methods and clinical practices that are available for studying low dose physiochemistry of candidate therapeutic compounds, helping to broaden the knowledge base of AMS application in pharmaceutical research.Keywords
This publication has 93 references indexed in Scilit:
- Significant Human β-Cell Turnover Is Limited to the First Three Decades of Life as Determined byin VivoThymidine Analog Incorporation and Radiocarbon DatingJournal of Clinical Endocrinology & Metabolism, 2010
- Accelerator Mass Spectrometry Can Be Used to Assess Vitamin A Metabolism Quantitatively in Boys in a Community SettingJournal of Nutrition, 2010
- Human microdosing for the prediction of patient responseBioanalysis, 2010
- Recent advances in biomedical applications of accelerator mass spectrometryJournal of Biomedical Science, 2009
- Measurement of 7,8-dihydro-8-oxo-2′-deoxyguanosine metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometryProceedings of the National Academy of Sciences of the United States of America, 2007
- Neocortical neurogenesis in humans is restricted to developmentProceedings of the National Academy of Sciences of the United States of America, 2006
- Human vitamin B 12 absorption measurement by accelerator mass spectrometry using specifically labeled 14 C-cobalaminProceedings of the National Academy of Sciences of the United States of America, 2006
- CommentaryBritish Journal of Clinical Pharmacology, 2006
- Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillationChemico-Biological Interactions, 2005
- Current perspectives of 14 C-isotope measurement in biomedical accelerator mass spectrometryAnalytical and Bioanalytical Chemistry, 2004